欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
Auranofin_34031-32-8_产品详情
34031-32-8
  • names:

    Auranofin

  • CAS号:

    34031-32-8

    MDL Number:
  • MF(分子式): C20H36AuO9PS MW(分子量): 680.5
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
Auranofin
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
YZM000010-10mg 10mg >98.0% ¥ 650.00 ¥ 650.00 2-3天
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名
英文别名
CAS号 34031-32-8
Inchi
InchiKey
分子式 Formula C20H36AuO9PS
分子量 Molecular Weight 680.5
溶解度Solubility 生物体外In Vitro:DMSO溶解度125 mg/mL(183.69 mM;Need ultrasonic and warming)H2O< 0.1 mg/mL(insoluble)
性状
储藏条件 Storage conditions 4°C, stored under nitrogen * In solvent : -80°C, 6 months月; -20°C, 1 month月 (stored under nitrogen)
Auranofin(CAS:34031-32-8)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
产品说明 Auranofin (SKF-39162)为硫氧还蛋白还原酶 (TrxR) 的抑制剂,IC50为0.2 μM
IntroductionAuranof in (SKF9162) is a thioredoxin reductase (TrxR) inhibitor with anIC50of 0.2 μM.
Application1
Application2
Application3
Auranofin (SKF-39162)为硫氧还蛋白还原酶 (TrxR) 的抑制剂,IC50为0.2 μM。Auranofin (SKF-39162) is a thioredoxin reductase (TrxR) inhibitor with anIC50of 0.2 μM.
警示图
危险性
危险性警示
安全声明
安全防护
备注
【1】.Cox AG, et al. The thioredoxin reductase inhibitor auranofin triggers apoptosis through a Bax/Bak-dependent process that involves peroxiredoxin 3 oxidation. Biochem Pharmacol. 2008 Oct 30;76(9):1097-109.
【2】.Park SH, et al. Auranofin displays anticancer activity against ovarian cancer cells through FOXO3 activation independent of p53. Int J Oncol. 2014 Oct;45(4):1691-8.
【3】.Park N, et al. Auranofin promotes mitochondrial apoptosis by inducing annexin A5 expression and translocation in human prostate cancer cells. J Toxicol Environ Health A. 2014;77(22-24):1467-76.
【4】.Lee JC, et al. Effect of auranofin treatment on aberrant splenic interleukin production in adjuvant arthritic rats. J Immunol. 1987 Nov 15;139(10):3268-74.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents